All News

Pfizer to stop selling Exubera

Pain meds injected into joint space may cause permanent damage.

Eaton Apothecary to distribute InforMedix Holdings' Med-eMonitor.

Groups say cancer drug dosing best measured by CMS, Medicaid.

Mirixa offers customizable newsletter, RxFYI, free newsletter for pharmacies

Predialysis patients can benefit from phosphate binders, an FDA advisory committee has decided.

Seattle pharmacist Beverly Schaefer has obtained funds to help pharmacies get involved in providing vaccinations.

S. Lawrence Kocot, former CMS adviser joins Sonnenschein Nath & Rosenthal

Confrontation with suicide bomber nets W.V. reservist an award for bravery.Confrontation with suicide bomber nets W.V. reservist an award for bravery.

Link suspected between diabetes drug, pancreatitis.

Apria Healthcare Group to acquire Coram.

FDA expands label for bortezomib (Velcade) for patients with impaired kidney function.

Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.

Topotecan granted FDA approval for relapsed small cell lung cancer.

Rite Aid and Lindora to expand California in-store clinics.

NABP awards DMEPOS accreditation to Walgreen Co.

Makers of homeopathic products push their cough and cold remedies in the wake of the withdrawal OTC cough and cold products for infants.

A new report requested by Rep. Henry Waxman finds that private insurers are not operating their Medicare Part D programs efficiently.

NCPA CEO Bruce Roberts urges members to get more involved in medication therapy management, e-prescribing, and lobbying legislators at annual convention.

Although the number of independent pharmacies has decreased from 2006, salary levels for pharmacists and technicians have increased.

WellPoint opens specialty pharmacy in airport

Dietary supplements confiscated by FDA

John Rector plans to step down from his position as general counsel for NCPA in 2008

FDA issues new warnings about Definity and Optison contrast agents

States look to expand Medicaid benefits and eligibility as the program enrollment and spending remain low.

Consumers Union, publisher of Consumer Reports, criticizes the Centers for Medicare & Medicaid Service's system for rating Medicare Part D prescription drug plans as meaningless.

Outcomes Pharmaceutical Health Care has released a new version of its medication therapy management (MTM) systems.

The eye care community is disconcerted by Genentech's decision to restrict access to its cancer drug Avastin.